Evidence brief · printable

Overactive Bladder evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Overactive Bladder: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/overactive-bladder.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Fesoterodine 8 trials
  • Mirabegron 6 trials
  • Botulinum toxin Type A 3 trials
  • ONO-8539 3 trials
  • Tolterodine 3 trials
  • Oxybutynin 2 trials

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Peripheral electrical and electromagnetic stimulation 24 trials · 10 completed · 2 with results
  • Education, coaching and self-management 6 trials · 5 completed · 1 with results
  • Wearables and monitoring devices 2 trials · 1 completed · 1 with results
  • Mindfulness, meditation and relaxation 2 trials · 1 completed · 1 with results
  • Psychotherapy, counselling and peer support 2 trials · 1 completed · 1 with results
  • Acupuncture and related techniques 10 trials · 2 completed · 0 with results

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection NCT06953271
  • Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder… NCT07195656
  • Zinc Supplementation With Botulinum Toxin for Overactive Bladder NCT07405554
  • Pelvic Health Electrically Evoked Recording (PEER) 2 Study NCT05200923
  • Efficacy of Electroacupuncture Versus Solifenacin Succinate for Female Overactive… NCT05798403
  • Percutaneous Nerve Evaluation Trial Time NCT06226220

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Among 8 trials of supplements and nutraceuticals found, none measured quality of life 11 trials of other approaches did
  • Among 8 trials of supplements and nutraceuticals found, none measured pain 10 trials of other approaches did
  • Among 47 trials of neuromodulation and electrical stimulation found, none measured mood, anxiety and wellbeing 6 trials of other approaches did
  • Oxygen, light, temperature and manual therapies: symptom severity and disease activity 12 trials, no results posted yet
  • Exercise and physical activity: symptom severity and disease activity 7 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (123 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.